The folate pathway enzymes, dihydropteroate synthase (DHPS) and dihydrofolatereductase (DHFR) are the targets for the sulfa drugs and Trimethoprim, respectively, which are used to treat diseases such as malaria, pneumocystis pneumonia (PCP), and, more recently, caMRSA infections. Here, DHPS is linked to pneumocystosis.